The role of drugs in the induction and/or exacerbation of psoriasis

被引:101
作者
Basavaraj, Kabbur Hanumanthappa [1 ]
Ashok, Navya Mysore [1 ]
Rashmi, Ramesh [1 ]
Praveen, Thaggikuppe Krishnamurthy [2 ]
机构
[1] JSS Univ, JSS Med Coll, Dept Dermatol Venereol & Leprosy, Mysore, Karnataka, India
[2] JSS Univ, JSS Coll Pharm, TIFAC CORE HD, Rocklands, Ooty, India
关键词
GENERALIZED PUSTULAR PSORIASIS; TUMOR-NECROSIS-FACTOR; ADRENORECEPTOR-BLOCKING-AGENTS; DEFECTIVE CHALONE MECHANISM; CHRONIC ACTIVE HEPATITIS; CYCLIC AMP CASCADE; LITHIUM-CARBONATE; ADENYL-CYCLASE; SKIN-LESIONS; ANTAGONIST THERAPY;
D O I
10.1111/j.1365-4632.2010.04570.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Psoriasis is a common skin disorder; knowledge of the factors that may induce, trigger, or exacerbate the disease is of primary importance in clinical practice. Drug intake is a major concern in this respect, as new drugs are constantly being added to the list of factors that may influence the course of this disease. Drug ingestion may result in exacerbation of pre-existing psoriasis, in induction of psoriatic lesions on clinically uninvolved skin in patients with psoriasis, or in precipitation of the disease in persons without family history of psoriasis or in predisposed individuals. In view of their relationship to drug-provoked psoriasis, therapeutic agents may be classified as drugs with strong evidence for a causal relationship to psoriasis, drugs about which there are considerable but insufficient data to support the induction or aggravation of the disease, and drugs that are occasionally reported to be associated with aggravation or induction. This review focuses on the most common causative agents for drug-induced, drug-triggered, or drug-aggravated psoriasis, such as beta-blockers, lithium, synthetic antimalarial drugs, nonsteroidal anti-inflammatory agents, and tetracyclines, and the mechanisms of action of these drugs in the pathogenesis of psoriasis.
引用
收藏
页码:1351 / 1361
页数:11
相关论文
共 127 条
[1]   DRUGS IN EXACERBATION OF PSORIASIS [J].
ABEL, EA ;
DICICCO, LM ;
ORENBERG, EK ;
FRAKI, JE ;
FARBER, EM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 15 (05) :1007-1022
[2]  
ABEL EA, 1992, SEMIN DERMATOL, V11, P269
[3]   The effect of inositol supplements on the psoriasis of patients taking lithium: a randomized, placebo-controlled trial [J].
Allan, SJR ;
Kavanagh, GM ;
Herd, RM ;
Savin, JA .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (05) :966-969
[4]  
Andersen M, 1991, Ugeskr Laeger, V153, P132
[5]   PRACTOLOL-INDUCED DRUG ERUPTION [J].
ASSEM, ESK ;
BANKS, RA .
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1973, 66 (02) :179-181
[6]   GENERALIZED PUSTULAR PSORIASIS - A CLINICAL AND EPIDEMIOLOGICAL STUDY OF 104 CASES [J].
BAKER, H ;
RYAN, TJ .
BRITISH JOURNAL OF DERMATOLOGY, 1968, 80 (12) :771-&
[8]  
BAKKER JB, 1976, PSYCHOSOMATICS, V17, P143
[9]  
BEROWA N, 1984, DTSCH DERMATOLOGE, V32, P1082
[10]   SYNERGISTIC INDUCTION OF INTERLEUKIN-6 BY TUMOR-NECROSIS-FACTOR AND LITHIUM-CHLORIDE IN MICE - POSSIBLE ROLE IN THE TRIGGERING AND EXACERBATION OF PSORIASIS BY LITHIUM TREATMENT [J].
BEYAERT, R ;
SCHULZEOSTHOFF, K ;
VANROY, F ;
FIERS, W .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (08) :2181-2184